CNR1 and neuropathy: To understand the potential molecular targets mediating the suppression of paclitaxel-induced neuropathy by WIN55212-2 and AM1710 after cessation of drug delivery, we examined the mRNA levels of markers of astrocytes and microglia as well as CB1 and CB2 receptor mRNA levels.